Federal projections suggest relaxing social distancing guidelines at the end of April will lead to a spike in infections. “We’re seeing the impact now of social distancing in the data and it seems to be working,” NateSilver538 says.
"Anyone who tells you we're going to have a vaccine in three or four months, that's just not the reality of how biology and research works," he said Wednesday.
Hahn said the government is trying to focus testing in hotspot areas where as many as 30% to 40% of those who get tested are positive, but that the efforts will need to be expanded. "Other countries like the U.K., Germany, South Korea have been able to do testing of millions of people. Why are we still so far behind? It was over a week ago that the Abbott test -- a rapid test -- was FDA approved, it is still not in widespread use," Raddatz said."This is preventing people from going back to work, getting out of quarantine.
While the FDA has authorized one type of antibody test, which will be able to detect if a person is immune to showing symptoms of the disease, he said there is an effort by the government underway to review information from other sources.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Empty churches, food drive mark start of Easter weekend in coronavirus-hit U.S.Political leaders and health experts urged Americans celebrating Good Friday and the Easter weekend under threat of the coronavirus to avoid church gatherings and observe the holidays at home as the U.S. death toll from COVID-19 surpassed 18,600.
Read more »
U.S. agencies back revoking ability of China Telecom to operate in U.S.The U.S. Justice Department and other federal agencies on Thursday called on the Federal Communications Commission (FCC) to revoke China Telecom (Americas) Corp's authorization to provide international telecommunications services to and from the United States.
Read more »
FDA grants approval of AstraZeneca's KoselugoThe U.S. Food and Drug Administration on Friday approved Koselugo, or selumetinib, to treat certain pediatric patients with neurofibromatosis type 1. The approval was given to AstraZeneca Pharmaceuticals LP. The FDA said neurofibromatosis type 1 is a genetic disorder of the nervous system that can cause tumors to grow on nerves, adding it is a "debilitating, progressive and often disfiguring rare disease that typically begins early in life.
Read more »
FDA warns Alex Jones to stop pitching bogus virus remediesU.S. health officials are warning conspiracy theorist and radio host Alex Jones to stop pitching bogus remedies for the coronavirus. The Food and Drug Administration sent a warning letter Thursday ordering Jones to stop falsely claiming that toothpaste, mouth wash and other products sponsored by his
Read more »